Successful use of topical cysteamine formulated from the oral preparation in a child with keratopathy secondary to cystinosis

American Journal of Ophthalmology

Volumn 138, Issue 4, 2004, Pages 674-675

  Khan, Arif O ^a   Latimer, Bruce ^a  

^a KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

MERCAPTAMINE;

CASE REPORT; CLINICAL FEATURE; CYSTINOSIS; HUMAN; KERATOPATHY; MALE; PHOTOPHOBIA; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 7044253246     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2004.05.005     Document Type: Article

References (5)

1. thed 1995 McGraw Hill New York 3763 3797
2. F. Iwata, E.M. Kuel, G.F Reed A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis Mol Genet Metab 64 1998 237 242
3. W.A. Gahl, E.M. Kuehl, F Iwata Corneal crystals in nephropathic cystinosis natural history and treatment with cysteamine eyedrops Mol Genet Metab 71 2000 100 120
4. L.A. Reynolds, R.G. Closson Extemporaneous ophthalmic preparations 1993 Applied Therapeutics Vancouver, Washington
5. European Agency For The Evaluation Of Medicinal Products, Committee For Proprietary Medicinal Products (CPMP) #230, 1997.